Hiv, Sexually Transmitted Diseases
Conditions
Keywords
HIV prevention education, STI prevention education, Pre-exposure prophylaxis (PrEP)
Brief summary
Pre-exposure prophylaxis (PrEP) is an important biomedical human immunodeficiency virus (HIV) prevention tool and may particularly benefit black, cis and trans-gender women, who are at an increased risk for HIV and Sexually Transmitted Infections (STIs). The purpose of this study is to use a population-based approach to create a cohort of cis and trans-gender women at risk for future HIV acquisition to better understand the factors associated with the risk of STIs and HIV diagnosis and predictors of PrEP use.
Detailed description
To better understand contextual factors among people who identify as women in Alabama that predict STI/HIV infection and PrEP use, we will refine an existing evidence-based mobile health app (HealthMpowerment or HMP) to optimally engage and retain a digital cohort of women at-risk for HIV infection (i.e. prior infection in the past 3 months with gonorrhea or syphilis). Using a sampling strategy based on geospatial analysis of HIV-risk, we will enroll and follow our cohort longitudinally to assess factors associated with incident STI/HIV infection as well as utilization of PrEP through iterative self-collected STI/HIV testing and survey assessments.
Interventions
BEHAVIORALCamelia Cohort
Through the HealthMpowerment (HMP) app tailored for women, we will be able to provide informational content, access to resources, PrEP locators and additional gamification features to optimally engage and retain our cohort, which may support linkage to PrEP care.
Sponsors
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
University of Alabama at Birmingham
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No
Inclusion criteria
* Self identify as a Cis-gender or Trans-gender woman * Age 18 - 89 * Reported STI in past 3 months by the Alabama Department of Public Health (ADPH) * Gonorrhea and Syphilis negative * HIV negative at screening encounter * Live in Alabama * Have access to a private smart phone
Exclusion criteria
* Live outside of Alabama * Positive diagnosis for HIV, Gonorrhea, or Syphilis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Annualized Sexually Transmitted Infections (STIs) | From time of enrollment through study completion at 24 months | We will calculate incidence of gonorrhea and new positive cases of syphilis. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pre-Exposure Prophylaxis (PrEP) uptake | From time of enrollment through study completion at 24 months | We will calculate incidence of PrEP initiation, as reported by participants and confirmed through medical record review or through Dried Blood Spot (DBS) sampling confirmed presence of tenofovir-base PrEP (TFV-dp). |
Countries
United States
Outcome results
None listed